These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32393834)

  • 1. The emerging roles of WBP2 oncogene in human cancers.
    Tabatabaeian H; Rao A; Ramos A; Chu T; Sudol M; Lim YP
    Oncogene; 2020 Jun; 39(24):4621-4635. PubMed ID: 32393834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo/MST blocks breast cancer by downregulating WBP2 oncogene expression via miRNA processor Dicer.
    Lim SK; Tabatabaeian H; Lu SY; Kang SA; Sundaram GM; Sampath P; Chan SW; Hong WJ; Lim YP
    Cell Death Dis; 2020 Aug; 11(8):669. PubMed ID: 32820148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal Regulation of Hippo and WBP2 Signalling-Implications in Cancer Therapy.
    Lim YX; Lin H; Seah SH; Lim YP
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WW domain-binding protein 2: an adaptor protein closely linked to the development of breast cancer.
    Chen S; Wang H; Huang YF; Li ML; Cheng JH; Hu P; Lu CH; Zhang Y; Liu N; Tzeng CM; Zhang ZM
    Mol Cancer; 2017 Jul; 16(1):128. PubMed ID: 28724435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway.
    Li Z; Lim SK; Liang X; Lim YP
    J Biol Chem; 2018 Dec; 293(52):20014-20028. PubMed ID: 30442712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WBP2 modulates G1/S transition in ER+ breast cancer cells and is a direct target of miR-206.
    Ren YQ; Wang HJ; Zhang YQ; Liu YB
    Cancer Chemother Pharmacol; 2017 May; 79(5):1003-1011. PubMed ID: 28391353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WBP2 inhibits microRNA biogenesis via interaction with the microprocessor complex.
    Tabatabaeian H; Lim SK; Chu T; Seah SH; Lim YP
    Life Sci Alliance; 2021 Jul; 4(7):. PubMed ID: 34117091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt Signaling Promotes Breast Cancer by Blocking ITCH-Mediated Degradation of YAP/TAZ Transcriptional Coactivator WBP2.
    Lim SK; Lu SY; Kang SA; Tan HJ; Li Z; Adrian Wee ZN; Guan JS; Reddy Chichili VP; Sivaraman J; Putti T; Thike AA; Tan PH; Sudol M; Virshup DM; Chan SW; Hong W; Lim YP
    Cancer Res; 2016 Nov; 76(21):6278-6289. PubMed ID: 27578003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated WBP2 Expression in HER2-positive Breast Cancers Correlates with Sensitivity to Trastuzumab-based Neoadjuvant Therapy: A Retrospective and Multicentric Study.
    Kang SA; Guan JS; Tan HJ; Chu T; Thike AA; Bernadó C; Arribas J; Wong CY; Tan PH; Gudi M; Putti TC; Sohn J; Lim SH; Lee SC; Lim YP
    Clin Cancer Res; 2019 Apr; 25(8):2588-2600. PubMed ID: 30593516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WBP2 negatively regulates the Hippo pathway by competitively binding to WWC3 with LATS1 to promote non-small cell lung cancer progression.
    Han Q; Rong X; Lin X; Zhang X; Fan C; Zhao H; Wang E
    Cell Death Dis; 2021 Apr; 12(4):384. PubMed ID: 33837178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WW domain binding protein 2 (WBP2) as an oncogene in breast cancer: mechanisms and therapeutic prospects-a narrative review.
    Liu Y; He E; Zhang Y; Liu Y; Wang Y; Chen S; Wu X; Zeng Y; Leng P
    Gland Surg; 2022 Dec; 11(12):1984-2002. PubMed ID: 36654949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WBP2 promotes BTRC mRNA stability to drive migration and invasion in triple-negative breast cancer via NF-κB activation.
    Lim YX; Lin H; Chu T; Lim YP
    Mol Oncol; 2022 Jan; 16(2):422-446. PubMed ID: 34197030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
    Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
    FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of E-box binding USF-1 by PI3K/AKT enhances its transcriptional activation of the WBP2 oncogene in breast cancer cells.
    Ramos A; Miow QH; Liang X; Lin QS; Putti TC; Lim YP
    FASEB J; 2018 Sep; ():fj201801167RR. PubMed ID: 30183375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WW domain-binding protein 2 overexpression prevents diet-induced liver steatosis and insulin resistance through AMPKβ1.
    Zheng Z; Li Y; Fan S; An J; Luo X; Liang M; Zhu F; Huang K
    Cell Death Dis; 2021 Mar; 12(3):228. PubMed ID: 33658485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. microRNA-485-5p inhibits the progression of hepatocellular carcinoma through blocking the WBP2/Wnt signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Signal; 2020 Feb; 66():109466. PubMed ID: 31706018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ.
    Chan SW; Lim CJ; Huang C; Chong YF; Gunaratne HJ; Hogue KA; Blackstock WP; Harvey KF; Hong W
    Oncogene; 2011 Feb; 30(5):600-10. PubMed ID: 20972459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine phosphorylation of transcriptional coactivator WW-domain binding protein 2 regulates estrogen receptor α function in breast cancer via the Wnt pathway.
    Lim SK; Orhant-Prioux M; Toy W; Tan KY; Lim YP
    FASEB J; 2011 Sep; 25(9):3004-18. PubMed ID: 21642474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription.
    Chen S; Wang H; Li Z; You J; Wu QW; Zhao C; Tzeng CM; Zhang ZM
    Br J Cancer; 2018 May; 119(2):182-192. PubMed ID: 29937544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.